Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA SUVEN LIFE SCIENCES DISHMAN PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 30.0 -20.5 - View Chart
P/BV x 3.3 5.8 57.6% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
SUVEN LIFE SCIENCES
Mar-23
DISHMAN PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs37494 399.3%   
Low Rs12945 286.4%   
Sales per share (Unadj.) Rs197.00.6 31,730.0%  
Earnings per share (Unadj.) Rs21.2-5.4 -390.7%  
Cash flow per share (Unadj.) Rs34.7-5.1 -677.4%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs179.917.2 1,045.1%  
Shares outstanding (eoy) m80.70218.07 37.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.3111.8 1.1%   
Avg P/E ratio x11.9-12.8 -92.8%  
P/CF ratio (eoy) x7.3-13.5 -53.5%  
Price / Book Value ratio x1.44.0 34.7%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,30715,131 134.2%   
No. of employees `000NANA-   
Total wages/salary Rs m5,355186 2,875.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,898135 11,742.2%  
Other income Rs m26584 314.1%   
Total revenues Rs m16,163220 7,350.9%   
Gross profit Rs m4,103-1,196 -343.0%  
Depreciation Rs m1,09165 1,666.8%   
Interest Rs m9445 17,553.9%   
Profit before tax Rs m2,334-1,183 -197.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6240-   
Profit after tax Rs m1,710-1,183 -144.6%  
Gross profit margin %25.8-883.6 -2.9%  
Effective tax rate %26.70-   
Net profit margin %10.8-873.5 -1.2%  
BALANCE SHEET DATA
Current assets Rs m11,0183,455 318.9%   
Current liabilities Rs m9,5171,050 906.1%   
Net working cap to sales %9.41,776.0 0.5%  
Current ratio x1.23.3 35.2%  
Inventory Days Days573,948 1.4%  
Debtors Days Days3218 1.6%  
Net fixed assets Rs m18,7871,373 1,368.1%   
Share capital Rs m161218 74.0%   
"Free" reserves Rs m14,3543,535 406.0%   
Net worth Rs m14,5163,753 386.8%   
Long term debt Rs m4,1890-   
Total assets Rs m29,8054,828 617.3%  
Interest coverage x3.5-218.8 -1.6%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.50 1,902.1%   
Return on assets %8.9-24.4 -36.5%  
Return on equity %11.8-31.5 -37.4%  
Return on capital %17.5-31.4 -55.9%  
Exports to sales %24.940.4 61.5%   
Imports to sales %3.7839.8 0.4%   
Exports (fob) Rs m3,95655 7,225.9%   
Imports (cif) Rs m5941,137 52.3%   
Fx inflow Rs m4,95255 9,043.8%   
Fx outflow Rs m6971,137 61.3%   
Net fx Rs m4,255-1,082 -393.1%   
CASH FLOW
From Operations Rs m2,786-1,031 -270.1%  
From Investments Rs m-1,529-2,606 58.7%  
From Financial Activity Rs m-9413,955 -23.8%  
Net Cashflow Rs m317317 99.7%  

Share Holding

Indian Promoters % 61.4 69.6 88.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 23.0 0.6 4,172.7%  
FIIs % 12.0 0.5 2,216.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 30.4 126.8%  
Shareholders   52,291 74,003 70.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Suven Life Sciences Share Price Performance

Period Dishman Pharma Suven Life Sciences S&P BSE HEALTHCARE
1-Day 2.87% 0.60% 1.18%
1-Month -2.45% -1.77% -0.75%
1-Year 96.38% 115.56% 61.82%
3-Year CAGR 89.34% 15.06% 18.16%
5-Year CAGR 38.20% -16.16% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.